Colorcon Executive and Leadership Team

Subodh Priolkar, the Chief Executive Officer at Colorcon, directs the overarching strategic vision for the organization. Priolkar architects long-term growth initiatives by aligning advanced coating systems and modified release technologies with evolving pharmaceutical industry requirements. This leadership role involves constant collaboration with the Board to ensure operational excellence across all global manufacturing sites. By prioritizing research and development, the Chief Executive Officer drives the creation of functional excipients that improve patient outcomes. Subodh Priolkar maintains a focus on market expansion, ensuring the company remains a premier supplier for pharmaceutical dosage forms. Through rigorous oversight of corporate governance and resource allocation, the Chief Executive Officer secures the competitive position of the firm. This executive leadership ensures that every technical support service meets the highest quality standards, ultimately fostering sustainable success within the complex global pharmaceutical supply chain.

Chandrabali Prajapati, the Chief Financial Officer, Functional Packaging (India) at Colorcon, directs all financial planning, reporting, and fiscal strategy for the Indian operations. Prajapati architects robust financial frameworks to support the production and distribution of functional packaging and excipients within the region. This leadership role involves managing capital investments and operational budgets to ensure maximum efficiency across manufacturing facilities. By overseeing financial risk management and compliance, the Chief Financial Officer, Functional Packaging (India) ensures the stability of regional business units. Chandrabali Prajapati collaborates with global finance leaders to maintain alignment with corporate fiscal policies while addressing the unique economic nuances of the Indian market. Through rigorous analysis of cost structures and revenue streams, the Chief Financial Officer, Functional Packaging (India) drives profitability and supports the expansion of technical support services. This financial oversight remains critical to the sustained growth and operational success of the company in the region.

Jen Kain, the Chief Technology Officer at Colorcon, directs the research and development of advanced coating systems and modified release technologies. Kain architects the technical roadmap for functional excipients, ensuring the company remains at the forefront of pharmaceutical innovation. This leadership role involves managing global laboratory operations and technical support teams to solve complex formulation challenges for pharmaceutical clients. By overseeing the integration of new materials into existing dosage form platforms, the Chief Technology Officer drives product efficacy and manufacturing efficiency. Jen Kain collaborates with the executive team to align technological advancements with long-term business objectives. Through the continuous evaluation of emerging scientific trends, the Chief Technology Officer ensures that the company provides cutting-edge solutions to the global pharmaceutical industry. This focus on technical precision and innovation supports the overall mission of delivering high-quality, reliable excipients that enhance the performance of pharmaceutical products worldwide.

Shannon Kelly, the Managing Director (Americas) at Colorcon, oversees all commercial operations and regional market penetration across the North American and South American territories. Kelly directs the implementation of technical support strategies for advanced coating systems, ensuring clients receive optimal solutions for pharmaceutical dosage forms. By managing regional sales teams, the Managing Director (Americas) drives revenue growth and strengthens relationships with key pharmaceutical manufacturers. This role requires constant coordination with global supply chain leaders to maintain consistent product availability. Shannon Kelly monitors regional market trends to adapt service delivery models, ensuring the company maintains a dominant presence in the Americas. Through strategic planning and operational oversight, the Managing Director (Americas) ensures that regional performance aligns with the broader corporate mission. This leadership focus guarantees that pharmaceutical partners receive the necessary functional excipients to meet demanding production schedules and regulatory requirements.